Evaluation of the Polysaccharide "Immeran" Activity in Syrian hamsters' Model of SARS-CoV-2

被引：0
作者：
Generalova, Liubov Viktorovna [1 ]
Laryushkin, Denis Pavlovich [2 ]
Leneva, Irina Anatolievna [3 ]
Ivanina, Anna Valerievna [3 ]
Trunova, Galina Vladimirovna [4 ]
Dolinnyi, Sergei Vladimirovich [1 ]
Generalov, Evgenii Aleksandrovich [5 ]
机构：
[1] Peoples Friendship Univ Russia, RUDN Univ, Fac Med, Moscow 117198, Russia
[2] Russian Acad Sci, Pushchino Sci Ctr Biol Res, Fed Res Ctr, Inst Cell Biophys, Pushchino 142290, Russia
[3] Mechnikov Res Inst Vaccines & Sera, Dept Virol, Moscow 105064, Russia
[4] Natl Med Res Radiol Ctr FSBI NMRRC, Minist Hlth Russian Federat, PA Hertsen Moscow, Fed State Budgetary Inst,Oncol Res Inst, Moscow 125284, Russia
[5] Lomonosov Moscow State Univ, Fac Phys, Moscow 119991, Russia
来源：
VIRUSES-BASEL | 2024年 / 16卷 / 03期
关键词：
Immeran; polysaccharide; Solanum tuberosum L; SARS-CoV-2; COVID-19; Syrian hamsters; respiratory disease; MULTICENTER; FAVIPIRAVIR; COVID-19;
D O I：
10.3390/v16030423
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
COVID-19 is a highly contagious respiratory disease with a high number of lethal cases in humans, which causes the need to search for new therapeutic agents. Polysaccharides could be one of the prospective types of molecules with a large variety of biological activities, especially antiviral. The aim of this work was to study the specific antiviral activity of the drug "Immeran" on a model of a new coronavirus infection SARS-CoV-2 in hamsters. Based on the second experiment, intraperitoneal treatment with the drug according to a treatment regimen in doses of 500 and 1000 mu g/kg (administration after an hour, then once a day every other day, a total of 3 administrations) was effective, reliably suppressing the replication of the virus in the lungs and, at a dose of 1000 mu g/kg, prevented weight loss in animals. In all cases, the treatment stimulated the formation of virus-neutralizing antibodies to the SARS-CoV-2 virus, which suggests that the drug possesses adjuvant properties.
引用
收藏
页数：15
相关论文
共 50 条
  • [1] A biomathematical model of SARS-CoV-2 in Syrian hamsters
    Schirm, Sibylle
    Nouailles, Geraldine
    Kirsten, Holger
    Trimpert, Jakob
    Wyler, Emanuel
    Alves, Luiz Gustavo Teixeira
    Landthaler, Markus
    Ahnert, Peter
    Suttorp, Norbert
    Witzenrath, Martin
    Scholz, Markus
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [2] Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development
    Imai, Masaki
    Iwatsuki-Horimoto, Kiyoko
    Hatta, Masato
    Loeber, Samantha
    Halfmann, Peter J.
    Nakajima, Noriko
    Watanabe, Tokiko
    Ujie, Michiko
    Takahashi, Kenta
    Ito, Mutsumi
    Yamada, Shinya
    Fan, Shufang
    Chiba, Shiho
    Kuroda, Makoto
    Guan, Lizheng
    Takada, Kosuke
    Armbrust, Tammy
    Balogh, Aaron
    Furusawa, Yuri
    Okuda, Moe
    Ueki, Hiroshi
    Yasuhara, Atsuhiro
    Sakai-Tagawa, Yuko
    Lopes, Tiago J. S.
    Kiso, Maki
    Yamayoshi, Seiya
    Kinoshita, Noriko
    Ohmagari, Norio
    Hattori, Shin-ichiro
    Takeda, Makoto
    Mitsuya, Hiroaki
    Krammer, Florian
    Suzuki, Tadaki
    Kawaoka, Yoshihiro
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (28) : 16587 - 16595
  • [3] Pathomorphological changes in the lung tissues of Syrian hamsters during experimental infection with SARS-COV-2
    Shestopalova, Lidia V.
    Lee, Wang
    Filippova, Anastasia Yu.
    Fedotova, Marina S.
    Kononova, Yulia V.
    Gulyaeva, Marina A.
    SOUTH OF RUSSIA-ECOLOGY DEVELOPMENT, 2024, 19 (03) : 55 - 62
  • [4] SARS-CoV-2 Delta Variant Pathogenesis and Host Response in Syrian Hamsters
    Mohandas, Sreelekshmy
    Yadav, Pragya Dhruv
    Shete, Anita
    Nyayanit, Dimpal
    Sapkal, Gajanan
    Lole, Kavita
    Gupta, Nivedita
    VIRUSES-BASEL, 2021, 13 (09):
  • [5] Age-Dependent Progression of SARS-CoV-2 Infection in Syrian Hamsters
    Osterrieder, Nikolaus
    Bertzbach, Luca D.
    Dietert, Kristina
    Abdelgawad, Azza
    Vladimirova, Daria
    Kunec, Dusan
    Hoffmann, Donata
    Beer, Martin
    Gruber, Achim D.
    Trimpert, Jakob
    VIRUSES-BASEL, 2020, 12 (07):
  • [6] Evaluation of a panel of therapeutic antibody clinical candidates for efficacy against SARS-CoV-2 in Syrian hamsters
    Cong, Yu
    Mucker, Eric M.
    Perry, Donna L.
    Dixit, Saurabh
    Kollins, Erin
    Byrum, Russ
    Huzella, Louis
    Kim, Robert
    Josleyn, Mathew
    Kwilas, Steven
    Stefan, Christopher
    Shoemaker, Charles J.
    Koehler, Jeff
    Coyne, Susan
    Delp, Korey
    Liang, Janie
    Drawbaugh, David
    Hischak, Amanda
    Hart, Randy
    Postnikova, Elena
    Vaughan, Nick
    Asher, Jason
    St Claire, Marisa
    Hanson, Jarod
    Schmaljohn, Connie
    Eakin, Ann E.
    Hooper, Jay W.
    Holbrook, Michael R.
    ANTIVIRAL RESEARCH, 2023, 213
  • [7] Golden Syrian Hamsters as a Model for Revisiting the Role of Biological Sex Differences in SARS-CoV-2 Infection
    Michita, Rafael Tomoya
    Mysorekar, Indira U.
    MBIO, 2021, 12 (06):
  • [8] Chemoprophylactic Assessment of Combined Intranasal SARS-CoV-2 Polymerase and Exonuclease Inhibition in Syrian Golden Hamsters
    Gallardo-Toledo, Eduardo
    Neary, Megan
    Sharp, Joanne
    Herriott, Joanne
    Kijak, Edyta
    Bramwell, Chloe
    Curley, Paul
    Arshad, Usman
    Pertinez, Henry
    Rajoli, Rajith K. R.
    Valentijn, Anthony
    Cox, Helen
    Tatham, Lee
    Kipar, Anja
    Stewart, James P.
    Owen, Andrew
    VIRUSES-BASEL, 2023, 15 (11):
  • [9] Vasculitis and Neutrophil Extracellular Traps in Lungs of Golden Syrian Hamsters With SARS-CoV-2
    Becker, Kathrin
    Beythien, Georg
    de Buhr, Nicole
    Stanelle-Bertram, Stephanie
    Tuku, Berfin
    Kouassi, Nancy Mounogou
    Beck, Sebastian
    Zickler, Martin
    Allnoch, Lisa
    Gabriel, Gulsah
    Von Kockritz-Blickwede, Maren
    Baumgaertner, Wolfgang
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [10] SARS-CoV-2 Variant Pathogenesis Following Primary Infection and Reinfection in Syrian Hamsters
    Plunkard, Jessica
    Mulka, Kathleen
    Zhou, Ruifeng
    Tarwater, Patrick
    Zhong, William
    Lowman, Margaret
    Wong, Amanda
    Pekosz, Andrew
    Villano, Jason
    MBIO, 2023, 14 (02):
12345